SCHEMBL5664686

SCHEMBL5664686

[CH2]C(O)C(=O)OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL167934 0.78 SMN1; SMN2 (0.48)
SCHEMBL258962 0.75
SCHEMBL127462 0.75
SCHEMBL16196001 0.75
SCHEMBL1097587 0.75
SCHEMBL1098657 0.75
SCHEMBL6064611 0.73 SMN1; SMN2 (0.50)
SCHEMBL13266324 0.73 SMN1; SMN2 (0.50)
SCHEMBL590895 0.73 SMN1; SMN2 (0.50)
SCHEMBL2039259 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 136 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101124199-A 5-substituted-2-phenylamino-benzamides as MEK inhibiting substances CHUGAI PHARMACEUTICAL CO LTD (JP) 2008-02-13 CN claimed
CN-1185211-C Benzamide derivatives for the treatment of diseases caused by cytokines ASTRA ZENECA LTD (SE) 2005-01-19 CN claimed
CN-1170827-C Benzofurylpyrone derivatives ������������ʽ���� 2004-10-13 CN claimed
CN-1481369-A Substituted phenyluracils compound �ݶ�ũ�����ѧ�ɷݹ�˾ 2004-03-10 CN claimed
EP-0659839-B1 Process for the preparation of pyrazolazo dyestuffs BAYER AG (DE) 2001-09-26 EP claimed
CN-1300278-A Benzamide derivatives for the treatment of diseases caused by cytokines ASTRA ZENECA LTD (SE) 2001-06-20 CN claimed
CN-1299359-A Benzofurylpyrone derivatives TEIJIN LTD (JP) 2001-06-13 CN claimed
US-5635534-A 1-PHENYL-2-(2-PHENYLOXY OR THIO)-1-METHYLETHYL)AMINOETHANOL DERIVATIVES; ALDOSE REDUCTASE INHIBITORS; NONTOXIC; ANTIDIABETIC,-OBESITY,-LIPEMIC AND HYPOGLYCEMIC AGENTS SANKYO COMPANY, LIMITED (JP) 1997-06-03 US claimed
CN-1034497-C Process for the preparation of aromatic aminoalcohol derivatives useful for the treatment of diabetes and obesity SANKYO CO (JP) 1997-04-09 CN claimed
EP-0543662-B1 Aromatic amino-alcohol derivatives having anti-diabetic and anti-obesity properties, their preparation and their therapeutic uses SANKYO CO (JP) 1996-09-18 EP claimed
CN-1073428-A Aromatic amino alcohol derivatives having anti-diabetic and anti-obesity properties, their preparation and their therapeutic use SANKYO CO (JP) 1993-06-23 CN claimed
EP-0543662-A2 Aromatic amino-alcohol derivatives having anti-diabetic and anti-obesity properties, their preparation and their therapeutic uses Sankyo Company Limited (JP) 1993-05-26 EP claimed
CN-87104156-A Benzo buprofezin derivate 1987-12-16 CN claimed
CN-87104046-A THIAZINONE DERIVATIVES 1987-12-16 CN claimed
CN-105073715-A Dihydropyridazine-3,5-dione derivative CHUGAI PHARMACEUTICAL CO LTD 2015-11-18 CN disclosed
CN-101522657-B STAT3/5 activation inhibitor OTSUKA PHARMACEUTICAL CO.,LTD. (JP) 2014-10-15 CN disclosed
CN-103476756-A 3-ureidoisoquinolin-8-yl derivatives ACTELION PHARMACEUTICALS LTD 2013-12-25 CN disclosed
CN-86102263-A A kind of novel androstane-17's preparation 1987-02-04 CN disclosed
EP-0008884-A1 Derivatives of clavulanic acid, a process for their preparation and their compositions BEECHAM GROUP PLC (GB) 1980-03-19 EP disclosed
EP-0007717-A1 Clavulanic acid derivatives, a process for their preparation, their use, and pharmaceutical compositions containing them BEECHAM GROUP PLC (GB) 1980-02-06 EP disclosed